Ped Zinc Tablets 20 mg

Land: Tanzania

Språk: engelska

Källa: Tanzania Medicinces & Medical Devices Authority

Ladda ner Produktens egenskaper (SPC)
27-02-2024

Aktiva substanser:

Zinc Sulfate Monohydrate

Tillgänglig från:

Shelys Pharmaceuticals Limited, TANZANIA

ATC-kod:

Other mineral supplements

INN (International namn):

Zinc Sulfate Monohydrate

Dos:

20 mg

Läkemedelsform:

Tablets

Tillverkad av:

Beta Healthcare International Limited, KENYA

Produktsammanfattning:

Physical description: A white circular bevel-edged flat tablets, with score line and de bossing with letter "S" and "L" on one side and plain on the other side; Local technical representative: Shelys Pharmaceuticals Limited (9387)

Bemyndigande status:

Registered/Compliant

Tillstånd datum:

2020-07-09

Produktens egenskaper

                                CEFOTAXIME FOR INJECTION USP 1g
1. Name of the medicinal
product
Cefotaxime for Injection USP 1g
2. Qualitative and quantitative composition
Each vial Contains:
Cefotaxime Sodium USP Equivalent to Cefotaxime ………1 g
3. Pharmaceutical form
Powder for injection or infusion.
Off white to pale yellow crystalline powder contained in 10 ml clear vials plugged with Grey
butyl rubber plug with blue colour Flip-off Seal.
4. Clinical particulars
4.1 Indications
Cefotaxime is indicated for the treatment of the following severe infections when known or
thought very likely to be due to bacteria that are susceptible to cefotaxime:
• Bacterial pneumonia; cefotaxime is not active against bacteria that cause atypical
pneumonia or against several other bacterial species that may cause pneumonia, including
P. aeruginosa.
• Complicated infections of the kidneys and upper urinary tract.
• Severe infections of the skin and soft tissue
• Genital infections caused by gonococci, particularly when penicillin has failed or is
unsuitable
• Intra-abdominal infections (such as peritonitis). Cefotaxime should be used in
combination with an antibiotic that is active against anaerobes in the treatment of intra-
abdominal infections.
• Acute bacterial meningitis (particularly if due to H. influenzae, N. meningitides, S.
pneumoniae, E. coli, Klebsiella spp.)
• Septicaemia infections originating from the lungs, urinary tract, or bowel (in case of gram-
negative organisms a combination with another suitable antibiotic should be considered).
Consideration should be given to official guidance on the appropriate use of antibacterial
agents.
4.2 Posology and method of administration
Cefotaxime may be administered by intravenous bolus injection, by intravenous infusion, by
intramuscular injection after reconstitution of the solution according to the directions given
below.
                                
                                Läs hela dokumentet
                                
                            

Sök varningar relaterade till denna produkt